Skip to main content
ArticleOPEN ACCESS

Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

European Journal of Health Economics
DOI: 10.1007/s10198-013-0538-4
60Citations
Citations of this article
84Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Farfan-Portet, M. I., Gerkens, S., Lepage-Nefkens, I., Vinck, I., & Hulstaert, F. (2014, April 1). Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures? European Journal of Health Economics. Springer Verlag. https://doi.org/10.1007/s10198-013-0538-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free